Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer.
Martínez VG, Rubio C, Martínez-Fernández M, Segovia C, López-Calderón F, Garín MI, Teijeira A, Munera-Maravilla E, Varas A, Sacedón R, Guerrero F, Villacampa F, de la Rosa F, Castellano D, López-Collazo E, Paramio JM, Vicente Á, Dueñas M. Martínez VG, et al. Among authors: teijeira a. Clin Cancer Res. 2017 Dec 1;23(23):7388-7399. doi: 10.1158/1078-0432.CCR-17-1004. Epub 2017 Sep 19. Clin Cancer Res. 2017. PMID: 28928159
DSTYK Inhibition Sensitizes NSCLC to Taxane-Based Chemotherapy.
Echepare M, Picabea B, Arricibita A, Teijeira Á, Pasquier A, Zandueta C, Otegui N, Santamaría E, Fernández-Irigoyen J, Romero O, Sanchez-Cespedes M, Lecanda F, Hernández J, Felip E, Cruz-Bermúdez A, Provencio M, Gentili M, Facchinetti F, Roz L, Montuenga LM, Valencia K. Echepare M, et al. Among authors: teijeira a. J Thorac Oncol. 2024 Nov 12:S1556-0864(24)02438-9. doi: 10.1016/j.jtho.2024.11.003. Online ahead of print. J Thorac Oncol. 2024. PMID: 39536877
Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.
Eguren-Santamaría I, Rodríguez I, Herrero-Martin C, Fernández de Piérola E, Azpilikueta A, Sánchez-Gregorio S, Bolaños E, Gomis G, Molero-Glez P, Chacón E, Mínguez JÁ, Chiva S, Diez-Caballero F, de Andrea C, Teijeira Á, Sanmamed MF, Melero I. Eguren-Santamaría I, et al. Among authors: teijeira a. Oncoimmunology. 2024 Jul 9;13(1):2373519. doi: 10.1080/2162402X.2024.2373519. eCollection 2024. Oncoimmunology. 2024. PMID: 38988823 Free PMC article.
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.
Teijeira A, Garasa S, Ochoa MC, Sanchez-Gregorio S, Gomis G, Luri-Rey C, Martinez-Monge R, Pinci B, Valencia K, Palencia B, Barbés B, Bolaños E, Azpilikueta A, García-Cardosa M, Burguete J, Eguren-Santamaría I, Garate-Soraluze E, Berraondo P, Perez-Gracia JL, de Andrea CE, Rodriguez-Ruiz ME, Melero I. Teijeira A, et al. Clin Cancer Res. 2024 Sep 13;30(18):4131-4142. doi: 10.1158/1078-0432.CCR-23-3860. Clin Cancer Res. 2024. PMID: 38630754 Free PMC article.
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis.
Bella Á, Arrizabalaga L, Di Trani CA, Gonzalez-Gomariz J, Gomar C, Russo-Cabrera JS, Olivera I, Cirella A, Fernandez-Sendin M, Alvarez M, Teijeira A, Atay C, Medina-Echeverz J, Hinterberger M, Hochrein H, Melero I, Berraondo P, Aranda F. Bella Á, et al. Among authors: teijeira a. J Immunother Cancer. 2023 Nov;11(11):e006702. doi: 10.1136/jitc-2023-006702. J Immunother Cancer. 2023. PMID: 37918917 Free PMC article.
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.
Melero I, Ochoa MC, Molina C, Sanchez-Gregorio S, Garasa S, Luri-Rey C, Hervas-Stubbs S, Casares N, Elizalde E, Gomis G, Cirella A, Berraondo P, Teijeira A, Alvarez M. Melero I, et al. Among authors: teijeira a. EMBO Mol Med. 2023 Nov 8;15(11):e17804. doi: 10.15252/emmm.202317804. Epub 2023 Oct 2. EMBO Mol Med. 2023. PMID: 37782273 Free PMC article.
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.
Cirella A, Bolaños E, Luri-Rey C, Di Trani CA, Olivera I, Gomis G, Glez-Vaz J, Pinci B, Garasa S, Sánchez-Gregorio S, Azpilikueta A, Eguren-Santamaria I, Valencia K, Palencia B, Alvarez M, Ochoa MC, Teijeira Á, Berraondo P, Melero I. Cirella A, et al. Among authors: teijeira a. Mol Ther Nucleic Acids. 2023 Jul 28;33:668-682. doi: 10.1016/j.omtn.2023.07.026. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37650116 Free PMC article.
86 results